Question 1

What safety data do we have about naratriptan from this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet clinical trial (NCT01376193). Contact the study team or your healthcare provider for specific answers.

Question 2

How does naratriptan compare to other migraine treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet clinical trial (NCT01376193). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of when taking naratriptan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet clinical trial (NCT01376193). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific health conditions that would make naratriptan unsafe for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet clinical trial (NCT01376193). Contact the study team or your healthcare provider for specific answers.

Question 5

How will we monitor my response to naratriptan if I decide to use it?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet clinical trial (NCT01376193). Contact the study team or your healthcare provider for specific answers.

What this study is about